Drug therapy - Pharmacogenomics - Drug disposition, drug targets, and side effects

被引：1175

作者：

Evans, WE

McLeod, HL

机构：

[1] St Jude Childrens Res Hosp, Memphis, TN 38101 USA

[2] Univ Tennessee, Coll Pharm, Memphis, TN USA

[3] Univ Tennessee, Coll Med, Memphis, TN USA

[4] Washington Univ, Sch Med, St Louis, MO USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 06期

关键词：

D O I：

10.1056/NEJMra020526

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：538 / 549

页数：12

共 96 条

[21] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

[22] Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine [J].

Evans, WE ;

Hon, YY ;

Bomgaars, L ;

Coutre, S ;

Holdsworth, M ;

Janco, R ;

Kalwinsky, D ;

Keller, F ;

Khatib, Z ;

Margolin, J ;

Murray, J ;

Quinn, J ;

Ravindranath, Y ;

Ritchey, K ;

Roberts, W ;

Rogers, ZR ;

Schiff, D ;

Steuber, C ;

Tucci, F ;

Kornegay, N ;

Krynetski, EY ;

Relling, MV .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2293-2301

[23] Pharmacogenomics: Translating functional genomics into rational therapeutics [J].

Evans, WE ;

Relling, MV .

SCIENCE, 1999, 286 (5439) :487-491

[24] Pharmacogenomics: The inherited basis for interindividual differences in drug response [J].

Evans, WE ;

Johnson, JA .

ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2001, 2 :9-39

[25] Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease [J].

Farlow, MR ;

Lahiri, DK ;

Poirier, J ;

Davignon, J ;

Schneider, L ;

Hui, SL .

NEUROLOGY, 1998, 50 (03) :669-677

[26] Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study [J].

Fellay, J ;

Marzolini, C ;

Meaden, ER ;

Back, DJ ;

Buclin, T ;

Chave, JP ;

Decosterd, LA ;

Furrer, H ;

Opravil, M ;

Pantaleo, G ;

Retelska, D ;

Ruiz, L ;

Schinkel, AH ;

Vernazza, P ;

Eap, CB ;

Telenti, A .

LANCET, 2002, 359 (9300) :30-36

[27] The apolipoprotein ε4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction -: A substudy of the Scandinavian Simvastatin Survival Study [J].

Gerdes, LU ;

Gerdes, C ;

Kervinen, K ;

Savolainen, M ;

Klausen, IC ;

Hansen, PS ;

Kesäniemi, YA ;

Færgeman, O .

CIRCULATION, 2000, 101 (12) :1366-1371

[28] Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. [J].

Herrington, DM ;

Howard, TD ;

Hawkins, GA ;

Reboussin, DM ;

Xu, JF ;

Zheng, SL ;

Brosnihan, KB ;

Meyers, DA ;

Bleecker, ER .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :967-974

[29] Genetic variations in HLA-B region and hypersensitivity reactions to abacavir [J].

Hetherington, S ;

Hughes, AR ;

Mosteller, M ;

Shortino, D ;

Baker, KL ;

Spreen, W ;

Lai, E ;

Davies, K ;

Handley, A ;

Dow, DJ ;

Fling, ME ;

Stocum, M ;

Bowman, C ;

Thurmond, LM ;

Roses, AD .

LANCET, 2002, 359 (9312) :1121-1122

[30] The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells [J].

Hitzl, M ;

Drescher, S ;

van der Kuip, H ;

Schäffeler, E ;

Fischer, J ;

Schwab, M ;

Eichelbaum, M ;

Fromm, MF .

PHARMACOGENETICS, 2001, 11 (04) :293-298

← 1 2 3 4 5 6 7 8 9 10 →